Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson’s disease: a prospective cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson’s disease: a prospective cohort study ; volume:21 ; number:1 ; day:6 ; month:11 ; year:2023 ; pages:1-14 ; date:12.2023
BMC medicine ; 21, Heft 1 (6.11.2023), 1-14, 12.2023
- Creator
-
Lin, Junyu
Ou, Ruwei
Li, Chunyu
Hou, Yanbing
Zhang, Lingyu
Wei, Qianqian
Pang, Dejiang
Liu, Kuncheng
Jiang, Qirui
Yang, Tianmi
Xiao, Yi
Zhao, Bi
Chen, Xueping
Song, Wei
Yang, Jing
Wu, Ying
Shang, Huifang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-023-03120-1
- URN
-
urn:nbn:de:101:1-2024012309150415130992
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lin, Junyu
- Ou, Ruwei
- Li, Chunyu
- Hou, Yanbing
- Zhang, Lingyu
- Wei, Qianqian
- Pang, Dejiang
- Liu, Kuncheng
- Jiang, Qirui
- Yang, Tianmi
- Xiao, Yi
- Zhao, Bi
- Chen, Xueping
- Song, Wei
- Yang, Jing
- Wu, Ying
- Shang, Huifang
- SpringerLink (Online service)
Other Objects (12)
Glial phagocytic clearance in Parkinson’s disease
Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson’s disease
Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Improved 3D measurement with a novel preprocessing method in DFP
Research on the difference of stroke characteristics and stroke effect between different stroke duration of table tennis players
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Genetic Architecture of Parkinson’s Disease
Glial phagocytic clearance in Parkinson’s disease
Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson’s disease
Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Improved 3D measurement with a novel preprocessing method in DFP
Research on the difference of stroke characteristics and stroke effect between different stroke duration of table tennis players
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Genetic Architecture of Parkinson’s Disease
Glial phagocytic clearance in Parkinson’s disease
Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson’s disease
Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Improved 3D measurement with a novel preprocessing method in DFP
Research on the difference of stroke characteristics and stroke effect between different stroke duration of table tennis players
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease